Correlation Between Voyager Therapeutics and TG Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Voyager Therapeutics and TG Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Voyager Therapeutics and TG Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Voyager Therapeutics and TG Therapeutics, you can compare the effects of market volatilities on Voyager Therapeutics and TG Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Voyager Therapeutics with a short position of TG Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Voyager Therapeutics and TG Therapeutics.

Diversification Opportunities for Voyager Therapeutics and TG Therapeutics

-0.48
  Correlation Coefficient

Very good diversification

The 3 months correlation between Voyager and TGTX is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Voyager Therapeutics and TG Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TG Therapeutics and Voyager Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Voyager Therapeutics are associated (or correlated) with TG Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TG Therapeutics has no effect on the direction of Voyager Therapeutics i.e., Voyager Therapeutics and TG Therapeutics go up and down completely randomly.

Pair Corralation between Voyager Therapeutics and TG Therapeutics

Given the investment horizon of 90 days Voyager Therapeutics is expected to under-perform the TG Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Voyager Therapeutics is 1.36 times less risky than TG Therapeutics. The stock trades about -0.21 of its potential returns per unit of risk. The TG Therapeutics is currently generating about -0.05 of returns per unit of risk over similar time horizon. If you would invest  3,095  in TG Therapeutics on October 20, 2024 and sell it today you would lose (140.00) from holding TG Therapeutics or give up 4.52% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Voyager Therapeutics  vs.  TG Therapeutics

 Performance 
       Timeline  
Voyager Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Voyager Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unfluctuating performance in the last few months, the Stock's technical and fundamental indicators remain relatively invariable which may send shares a bit higher in February 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.
TG Therapeutics 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in TG Therapeutics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly conflicting basic indicators, TG Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Voyager Therapeutics and TG Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Voyager Therapeutics and TG Therapeutics

The main advantage of trading using opposite Voyager Therapeutics and TG Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Voyager Therapeutics position performs unexpectedly, TG Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TG Therapeutics will offset losses from the drop in TG Therapeutics' long position.
The idea behind Voyager Therapeutics and TG Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets